Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 15/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11338319 | 0.96 | SIGMAR1 (0.44) | SIGMAR1OPRK1OPRM1MEN1ALDH1A1 | |
| SCHEMBL11446429 | 0.89 | SIGMAR1 (0.51) | SIGMAR1OPRK1MEN1ALDH1A1RAB9A | |
| SCHEMBL11343008 | 0.85 | SIGMAR1 (0.53) | SIGMAR1OPRK1MEN1ALDH1A1RAB9A | |
| SCHEMBL11338316 | 0.81 | SIGMAR1 (0.44) | SIGMAR1OPRK1OPRM1MEN1ALDH1A1 | |
| SCHEMBL11447938 | 0.81 | SIGMAR1 (0.53) | SIGMAR1OPRK1OPRM1 | |
| SCHEMBL11454746 | 0.79 | SIGMAR1 (0.51) | SIGMAR1OPRK1MEN1ALDH1A1RAB9A | |
| SCHEMBL11454754 | 0.78 | SIGMAR1 (0.53) | SIGMAR1OPRK1OPRM1MEN1ALDH1A1 | |
| SCHEMBL11454732 | 0.77 | SIGMAR1 (0.52) | SIGMAR1OPRK1OPRM1MEN1ALDH1A1 | |
| SCHEMBL11446437 | 0.77 | MEN1 (0.39) | OPRM1MEN1ALDH1A1TP53KMT2A | |
| SCHEMBL11341263 | 0.77 | SIGMAR1 (0.55) | SIGMAR1OPRK1OPRM1MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4204003-A | N-(2-Aminocyclopentyl)-N-alkanoylanilides as CNS anti-depressants | THE UPJOHN COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4159340-A | N-(2-Aminocyclopentyl)-N-acylanilides as CNS anti-depressants | THE UPJOHN COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-4157398-A | N-(2-Aminocyclopentyl)acylanilides and treating depression | THE UPJOHN COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4156733-A | ANTIDEPRESSANTS | THE UPJOHN COMPANY (US) | 1979-05-29 | — | — | US | disclosed |
| US-4156015-A | N-(2-Aminocyclopentyl)acylanilides and treating depression | THE UPJOHN COMPANY (US) | 1979-05-22 | — | — | US | disclosed |
| US-4148913-A | ANTIDEPRESSANTS | THE UPJOHN COMPANY (US) | 1979-04-10 | — | — | US | disclosed |